Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Noninvasive brain stimulation for carpal tunnel syndrome treatment

Official title: Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Run by Spaulding Rehabilitation Hospital · NCT04206215 · Data updated 2026-11-12

This study is testing if a new noninvasive brain stimulation treatment can help reduce pain for people with Carpal Tunnel Syndrome.

More Chronic Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment95 (estimated)
SponsorSpaulding Rehabilitation Hospital
Academic / other
Locations1 site (Charlestown, Massachusetts)
StatusRecruiting
StartedApril 16, 2021
Main results expectedJuly 2, 2027
Study endsDecember 28, 2027
Registry record updatedAugust 18, 2026
Trial IDNCT04206215 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 80 with chronic pain from symptomatic Carpal Tunnel Syndrome that has not responded to first-line therapies.

Probably not a fit

Patients who are pregnant or have contraindications to tDCS and TUS, such as intracranial metal implants, will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of transcranial Direct Current Stimulation (tDCS) combined with Transcranial Ultrasound (TUS) in reducing pain for patients suffering from Carpal Tunnel Syndrome (CTS). The researchers hypothesize that active stimulation will lead to a significant decrease in pain levels compared to sham stimulation. Participants will be monitored for changes in pain intensity over the course of the intervention. The study aims to provide a noninvasive treatment option for chronic pain associated with CTS.

Why it matters

Potential benefit: If successful, this approach could offer a new noninvasive treatment option for patients with chronic pain from Carpal Tunnel Syndrome.

How similar studies have gone: Other studies have shown promise with noninvasive brain stimulation techniques for pain management, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Able to provide informed consent to participate in the study
2. Subjects between 18 to 80 years old
3. Having symptomatic CTS spreading within or beyond the median nerve distribution (demonstrating 'extra-median spread'), involving at least 1 wrist, with chronic pain as defined by International Association for the Study of Pain (existing pain for at least 6 months and having pain on at least half the days in the past 6 months with an average of at least a 3 on a 0-10 VAS scale).
4. Pain resistant to first line therapies of chronic pain (pain still present at lower levels most of the time following therapy)
5. Must have the ability to feel pain as self-reported.

Exclusion Criteria:

1. Subject is pregnant
2. Contraindications to tDCS+TUS:

   1. intracranial metal implant
   2. implanted brain medical devices
3. History of alcohol or drug abuse within the past 6 months as self-reported
4. Use of carbamazepine within the past 6 months as self-reported
5. Suffering from major depression (with a PHQ-9 score of ≥20)
6. History of neurological disorders involving stroke, brain tumors, or epilepsy with residual neurological symptoms as self-reported (note patients will also be evaluated via EEG at baseline about 1 week prior to stimulation and any patient showing abnormal EEG activity will be removed))
7. History of unexplained fainting spells as self-reported
8. History of head injury resulting in more than a momentary loss of consciousness as self-reported and with current neurological deficits
9. History of intracranial neurosurgery as self-reported

Where it's running

  • Spaulding Rehabilitation Network Research Institute
    Charlestown, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Felipe Fregni, MD PhD MPH — Spaulding Rehabilitation Network
  • Study coordinator: Felipe Fregni, MD PhD mph
  • Email: ffregni@partners.org
  • Phone: 617-952-6156

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work

    This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.

    Recruiting at 2 sites Karolinska Institutet · Luleå, Norrbotten County and 2 other locations · NCT07924774

  • One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital

    A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.

    Recruiting Ottawa Hospital Research Institute · Ottawa, Ontario · NCT07919626

  • Meaning-Based Psychotherapy for Adults with Chronic Pain

    This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.

    Recruiting Hospital Clinico Universitario San Cecilio · Granada, Granada · NCT07915440

  • How chronic pain changes over time in kids with Duchenne Muscular Dystrophy

    This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.

    Recruiting Antalya Training and Research Hospital · Antalya, Antalya · NCT07892196

  • CBD for Opioid Dependence and Pain on Buprenorphine

    This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.

    Recruiting Early Phase 1 Yale University · West Haven, Connecticut · NCT07886606

  • Cebranopadol for opioid withdrawal in adults with chronic pain

    This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.

    Recruiting at 2 sites Phase 2 Adneuris Therapeutics, Inc. · North Canton, Ohio and 1 other locations · NCT07874620

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.